André Bessa Aguiar
Research Subjects
Research Interests
André Bessa Aguiar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Júlio César Claudino dos Santos
Universidade Federal Fluminense (UFF) Niterói RJ Brazil
2 shared publications - Micael Porto Portela Lima
Centro Universitário Christus
2 shared publications - Alan Bessa Aguiar
University Center Christus
1 shared publication - Alexandre Chaves Fernandes
Instituto Internacional de Neurociências Edmond e Lily Safra, Macaíba, RN, Brazil
1 shared publication - Felipe Micelli Noleto
Christus University
1 shared publication - Gabriel Romão Mesquita Do Nascimento
University Center Christus
1 shared publication
Latest Publications
- Open Access
- 1 October 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (10)
Neuropsychiatric and cognitive comorbidities in epilepsy
The epileptic crisis is characterized by a momentary episode of signs and symptoms that are caused by abnormal excessive or synchronous neuronal activity in the brain. On the other hand, epileptic syndrome is defined, according to the International League Against Epilepsy (ILAE), by “a group of clinical and neuroimaging characteristics in electroencephalographic (EEG) findings, many times, supported by specific etiologic findings (structural, genetic, metabolic, immunological and infectious)”. Accordingly, epilepsy patients have multiple neuropsychiatric comorbidities, being depressive disorders the most common, a condition that affects the quality of life and is influenced by numerous external factors. The present study aims to conduct a literature review based on the analysis of articles published from 2010 to 2022 in the PubMed (Medline) and Science Direct databases on epilepsy, its cognitive compromising and its neuropsychiatric comorbidities, using the terminology indicated by the System of Descriptors in Health Sciences (DeCS) and a set of predetermined criteria to select the best articles on the subject. Therefore, approaching psychiatric comorbidities, such as depressive disorders and cognitive deficiencies, in epilepsy is essential in light of its high prevalence and the negative repercussions in the patient's life. Consequently, more in-depth studies are necessary to provide a better prognosis for epilepsy patients and to evaluate the side effects and the clinical repercussions of Anti-Epileptic Drugs (AEDs).
- 1 October 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (10)
Open AccessNeuropsychiatric and cognitive comorbidities in epilepsy
The epileptic crisis is characterized by a momentary episode of signs and symptoms that are caused by abnormal excessive or synchronous neuronal activity in the brain. On the other hand, epileptic syndrome is defined, according to the International League Against Epilepsy (ILAE), by “a group of clinical and neuroimaging characteristics in electroencephalographic (EEG) findings, many times, supported by specific etiologic findings (structural, genetic, metabolic, immunological and infectious)”. Accordingly, epilepsy patients have multiple neuropsychiatric comorbidities, being depressive disorders the most common, a condition that affects the quality of life and is influenced by numerous external factors. The present study aims to conduct a literature review based on the analysis of articles published from 2010 to 2022 in the PubMed (Medline) and Science Direct databases on epilepsy, its cognitive compromising and its neuropsychiatric comorbidities, using the terminology indicated by the System of Descriptors in Health Sciences (DeCS) and a set of predetermined criteria to select the best articles on the subject. Therefore, approaching psychiatric comorbidities, such as depressive disorders and cognitive deficiencies, in epilepsy is essential in light of its high prevalence and the negative repercussions in the patient's life. Consequently, more in-depth studies are necessary to provide a better prognosis for epilepsy patients and to evaluate the side effects and the clinical repercussions of Anti-Epileptic Drugs (AEDs).
- Open Access
- 30 May 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (6)
Prevalence of somatic small fiber neuropathy in elderly: a review
Somatic small fiber neuropathy (SSFN) is a neuromuscular disease that affects peripheral nerves and leads to structural and functional changes involving small myelinated (Aδ) and unmyelinated (C) fibers, and whose pathophysiological mechanisms are not well elucidated, but depend on the underlying etiology. Due to the lack of studies on this pathology, it is likely to be underdiagnosed, which is a problem, since this disease in elderly people can lead to multiple negative effects on daily life due to neuropathic pain, paresthesia, and dysautonomia of various systems. The clinical diagnosis of this pathology is based on data from the clinical history and physical examination, as well as some complementary examinations and tests, such as the quantitative sudomotor axon reflex test (QSART). Moreover, the treatment of the disease is still limited and most approaches focus on the control of symptoms, such as neuropathic pain. The present study consists of a narrative review of the literature conducted in Medline databases from 2010 to 2022 on small-fiber neuropathy, the elderly, and neuralgia, using the terminology indicated by the Health Sciences Descriptor System (DeCS), and aims to highlight the relevance of the association of senile comorbidities and the aging process with somatic small-fiber neuropathy. Thus, future studies investigating the pathophysiological mechanisms of SSFN are of utmost importance, as well as studies aimed at developing more effective diagnostic methods.
- 30 May 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (6)
Open AccessPrevalence of somatic small fiber neuropathy in elderly: a review
Somatic small fiber neuropathy (SSFN) is a neuromuscular disease that affects peripheral nerves and leads to structural and functional changes involving small myelinated (Aδ) and unmyelinated (C) fibers, and whose pathophysiological mechanisms are not well elucidated, but depend on the underlying etiology. Due to the lack of studies on this pathology, it is likely to be underdiagnosed, which is a problem, since this disease in elderly people can lead to multiple negative effects on daily life due to neuropathic pain, paresthesia, and dysautonomia of various systems. The clinical diagnosis of this pathology is based on data from the clinical history and physical examination, as well as some complementary examinations and tests, such as the quantitative sudomotor axon reflex test (QSART). Moreover, the treatment of the disease is still limited and most approaches focus on the control of symptoms, such as neuropathic pain. The present study consists of a narrative review of the literature conducted in Medline databases from 2010 to 2022 on small-fiber neuropathy, the elderly, and neuralgia, using the terminology indicated by the Health Sciences Descriptor System (DeCS), and aims to highlight the relevance of the association of senile comorbidities and the aging process with somatic small-fiber neuropathy. Thus, future studies investigating the pathophysiological mechanisms of SSFN are of utmost importance, as well as studies aimed at developing more effective diagnostic methods.